Although we could not find any experimental validation for the BTRC-miR-107 interaction, a study by Yang et al. [163] found that a combination of miR-107-BTRC-UBR3-miR-16 expression could distinguish between different BC subtypes, specifically between basal-like tumors and luminal types [163]. The gene discussed is UBR3; the disease is breast cancer.